This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017
to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable
diseases. The evaluation combines both quantitative and qualitative analysis. The findings confirm that the Programme has contributed to a significant increase in access to needed outpatient medicines in Ukraine. Further, while implementation was successful overall, uptake across regions was uneven. The report concludes by listing a number of policy options to support the sustainability and expansion of the Affordable Medicines Programme.